SALL4 Is a Novel Sensitive and Specific Marker of Ovarian Primitive Germ Cell Tumors and Is Particularly Useful in Distinguishing Yolk Sac Tumor From Clear Cell Carcinoma
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Ovarian primitive germ cell tumors (GCTs) are uncommon tumors and sometimes pose diagnostic challenges. Among them, yolk sac tumor (YST) poses the greatest diagnostic difficulty and can be mistaken for clear cell carcinoma (CCC). Current immunohistochemical markers such as alpha-fetoprotein (AFP), glypican-3, cytokeratin (CK) 7, and epithelial membrane antigen (EMA) used to distinguish YST from CCC lack adequate sensitivity and specificity. Here by immunohistochemistry, we investigated a novel marker SALL4 in 98 GCTs (29 YSTs, 18 dysgerminomas, 6 gonadoblastomas, 6 embryonal carcinomas, 15 immature and 12 mature teratomas, 7 carcinoid tumors, 3 strumal carcinoids, and 2 struma ovarii) with particular interest of exploring SALL4 to distinguish YST from CCC. One hundred sixty-three non-GCTs including 45 CCCs were also stained. We found that SALL4 is strongly positive in more than 90% tumor cells in all YSTs, dysgerminomas, gonadoblastomas, and embryonal carcinomas. Variable SALL4 staining is seen in 11 of 15 immature teratomas. All other GCTs included in this study are negative for SALL4. Except 3 CCCs with focal SALL4 staining (<15% tumor cells), SALL4 is negative in the remaining 160 non-GCTs. We also compared SALL4 with AFP, glypican-3, CK7, and EMA in all YSTs and CCCs. AFP and glypican-3 are positive in 24 (83%) and 20 (69%) YSTs, respectively, whereas 16 (35%) and 13(28%) CCCs show positive AFP and glypican-3 staining, respectively. Three (10%) and 4 (14%) YSTs show focal (<2% tumor cells) CK7 and EMA staining, respectively. CK7 and EMA are positive in all 45 CCCs but 3 (7%) and 1 (2%) cases show staining in less than 30% tumor cells, respectively. Our findings indicate that SALL4 is a novel sensitive and specific marker for ovarian primitive GCTs. SALL4 is particularly useful in distinguishing YST from CCC and better than AFP, glypican-3, CK7, and EMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, J., Tam, W.-L., Tong, G. Q., Wu, Q., Chan, H.-Y., Soh, B.-S., Lou, Y., Yang, J., Ma, Y., Chai, L., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1481 · Cited by 568 · cited 1×
“SALL4 is a stem cell marker in the same family as OCT4 and seems to regulate OCT4 transcription.(15,31,34,35) The goal of this study is to investigate the utility of SALL4 as a potential diagnostic marker for ovarian GCTs, with particular interest in exploring SALL4 to distinguish YST from CCC.”
BackgroundSakaki-Yumoto, M., Kobayashi, C., Sato, A., Fujimura, S., Matsumoto, Y., Takasato, M., Kodama, T., Aburatani, H., Asashima, M., Yoshida, N., et al. (2006) · Development · doi:10.1242/dev.02457 · Cited by 264 · cited 2×
“Mutations in SALL4 lead to acro-renal-ocular and Okihiro syndromes.(11,25) In human embryonic stem cells, SALL4 is essential to maintain embryonal stem cell pluripotency and selfrenewal by forming a regulatory network with OCT4, NANOG, and SOX2.”
BackgroundHead and tail development of the Drosophila embryo involves spalt, a novel homeotic gene
Jürgens, G. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02799.x · Cited by 145 · cited 1×
“In Drosophila sal acts as a region-specific homeotic gene and plays an important role in the specification of head and tail regions during embryonal development.(9) In mouse, Sall4 is essential to early embryogenesis and proliferation of embryonic stem cells.”
BackgroundWarren, M., Wang, W., Spiden, S., Chen‐Murchie, D., Tannahill, D., Steel, K. P., & Bradley, A. (2007) · genesis · doi:10.1002/dvg.20264 · Cited by 69
Cited by
SALL4, the missing link between stem cells, development and cancer
Tatetsu, H., Kong, N. R., Chong, G., Amabile, G., Tenen, D. G., & Chai, L. (2016) · Gene · doi:10.1016/j.gene.2016.02.019 · Cited by 130
Role of SALL4 in the progression and metastasis of colorectal cancer
Forghanifard, M. M., Moghbeli, M., Raeisossadati, R., Tavassoli, A., Mallak, A. J., Boroumand-Noughabi, S., & Abbaszadegan, M. R. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-6 · Cited by 82
“Nonetheless, SALL4 expression is reported in numerous malignancies, such as breast and lung cancers [14,15], precursor B-cell lymphoblastic lymphoma [16], myelodysplastic syndromes (MDS) [11], acute myeloid leukemia (AML) [10,11], endometriotic samples [17], ovarian germ cell tumors [18], all types of testicular germ…”
BackgroundGao, C., Dimitrov, T., Yong, K. J., Tatetsu, H., Jeong, H.-W., Luo, H. R., Bradner, J. E., Tenen, D. G., & Chai, L. (2013) · Blood · doi:10.1182/blood-2012-04-424275 · Cited by 65
Liu, T.-C., Vachharajani, N., Chapman, W. C., & Brunt, E. M. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000218 · Cited by 37
“Total patient number 236 (100) Male:Female 165:71 (70:30) Median age (range) 59 y old (19-83) Ethnicity White 185 (78.”
Background
Metadata
- Authors
- Cao, D., Guo, S., Allan, R. W., Molberg, K. H., & Peng, Y.
- Venue
- American Journal of Surgical Pathology
- Published
- 2009-06
- Volume
- 33
- Issue
- 6
- Pages
- 894-904
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2014246282
- Cited by
- 207
- References
- 4
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SALL4 Is a Novel Sensitive and Specific Marker of Ovarian Primitive Germ Cell Tumors and Is Particularly Useful in Distinguishing Yolk Sac Tumor From Clear Cell Carcinoma. https://app.cochat.ai/papers/10.1097/pas.0b013e318198177d
- The paper
- Cao, D., Guo, S., Allan, R. W., Molberg, K. H., & Peng, Y. (2009). SALL4 Is a Novel Sensitive and Specific Marker of Ovarian Primitive Germ Cell Tumors and Is Particularly Useful in Distinguishing Yolk Sac Tumor From Clear Cell Carcinoma. American Journal of Surgical Pathology. https://doi.org/10.1097/pas.0b013e318198177d
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.